INACTIVATED POLIOMYELITIS VACCINE (DIPLOID CELL ORIGIN) - IPV DIN 02231267
Status: Cancelled Post Market
Holder: SANOFI VACCINES CANADA LTD.
Health Canada record
| Active ingredient(s) | INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY 40 UNIT; INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 8 UNIT; INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT 32 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07BF03 POLIOMYELITIS, TRIVALENT, INACTIVATED, WHOLE VIRUS |
| Original market date | 17-Nov-1998 |
| Current status date | 19-Sep-2014 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanofi Vaccines Canada Ltd. — licence 101420, currently licensed, last inspection rating C (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00615358 | TD POLIO ADSORBED | SANOFI VACCINES CANADA LTD. | Suspension | INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY 40 UNIT; INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 8 UNIT; INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT 32 UNIT; TETANUS TOXOID 5 LF; DIPHTHERIA TOXOID 2 LF | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7581 | 2005-10-28 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 1417 | 2000-03-17 | New Drug Submission (NDS) |